Characterization and Applications of New Hyper-Cross-Linked Cyclodextrins
Nanosponges are recently developed hyper-cross-linked cyclodextrin polymers nanostructured to form 3-dimensional networks; they are obtained by reacting cyclodextrin with a cross-linker such as carbonyldiimidazole. Nanosponges can be synthesized in neutral or acidic forms, depending in turn on the a...
Saved in:
| Published in | Composite interfaces Vol. 16; no. 1; pp. 39 - 48 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Taylor & Francis Group
01.01.2009
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Nanosponges are recently developed hyper-cross-linked cyclodextrin polymers nanostructured to form 3-dimensional networks; they are obtained by reacting cyclodextrin with a cross-linker such as carbonyldiimidazole. Nanosponges can be synthesized in neutral or acidic forms, depending in turn on the agent used as cross-linker. They are solid nanoparticles and can be prepared in crystalline form with spherical shape using an ultrasound-assisted preparation method. The average diameter of a nanosponge is below 1 μm but fractions below 500 nm can be selected. Nanosponges can encapsulate various types of molecules by forming inclusion and non-inclusion complexes. In this study we used dexamethasone as model molecule; up to 35% could be incorporated. Nanosponges could be used to increase aqueous solubility of poorly water-soluble drugs, to remove pollutants from contaminated water, or as nanocarriers for biomedical applications. |
|---|---|
| AbstractList | Nanosponges are recently developed hyper-cross-linked cyclodextrin polymers nanostructured to form 3-dimensional networks; they are obtained by reacting cyclodextrin with a cross-linker such as carbonyldiimidazole. Nanosponges can be synthesized in neutral or acidic forms, depending in turn on the agent used as cross-linker. They are solid nanoparticles and can be prepared in crystalline form with spherical shape using an ultrasound-assisted preparation method. The average diameter of a nanosponge is below 1 μm but fractions below 500 nm can be selected. Nanosponges can encapsulate various types of molecules by forming inclusion and non-inclusion complexes. In this study we used dexamethasone as model molecule; up to 35% could be incorporated. Nanosponges could be used to increase aqueous solubility of poorly water-soluble drugs, to remove pollutants from contaminated water, or as nanocarriers for biomedical applications. |
| Author | Trotta, Francesco Cavalli, Roberta |
| Author_xml | – sequence: 1 givenname: Francesco surname: Trotta fullname: Trotta, Francesco – sequence: 2 givenname: Roberta surname: Cavalli fullname: Cavalli, Roberta |
| BookMark | eNp1kE1LxDAYhIOsYHf17rF_IJo2aZPiaSnqLix6UfBW3uYDo92kJIW1_nrbXU-Cp2EGnmGYJVo47zRC1xm5ybKS3mZFKYqCEfFGeUWFOEPJHOEpowuUkCrnuGSMXKBljB-E5IxwkqBt_Q4B5KCD_YbBepeCU-m67zsrjz6m3qRP-pBuxl4HXAcfI95Z96lVWo-y80p_DcG6eInODXRRX_3qCr0-3L_UG7x7ftzW6x2WeVUMGAqmWWukUUwpMFKXvGValkBEZVRbUSo4pwwYpbxoS1UxIQ01hFPDpZpkhcipV85TgjZNH-wewthkpJmvaP5eMSF3J8Q648MeDj50qhlg7HwwAZy0saH_0j_nmWd2 |
| CitedBy_id | crossref_primary_10_1002_wnan_1384 crossref_primary_10_1007_s10847_019_00903_z crossref_primary_10_1016_j_jddst_2023_105084 crossref_primary_10_3762_bjoc_8_235 crossref_primary_10_1517_17425247_2015_1026893 crossref_primary_10_3851_IMP1684 crossref_primary_10_1002_cjoc_201300270 crossref_primary_10_2478_acph_2013_0021 crossref_primary_10_3109_10717541003777233 crossref_primary_10_1016_j_ijpharm_2017_06_072 crossref_primary_10_1517_17425247_2014_911729 crossref_primary_10_1016_S2222_1808_14_60667_8 crossref_primary_10_1002_jrs_4282 crossref_primary_10_3390_c7030056 crossref_primary_10_1208_s12249_011_9584_3 crossref_primary_10_3390_molecules26175193 crossref_primary_10_1016_j_carbpol_2015_10_080 crossref_primary_10_1016_j_jddst_2022_103100 crossref_primary_10_1007_s10856_022_06652_9 crossref_primary_10_1039_C6RA06143E crossref_primary_10_1016_j_fct_2019_110647 crossref_primary_10_1016_j_foodhyd_2018_10_003 crossref_primary_10_1186_s11671_017_2072_2 crossref_primary_10_1016_j_jddst_2020_101643 crossref_primary_10_1007_s10847_012_0192_y crossref_primary_10_3390_gels8010055 crossref_primary_10_1007_s10965_023_03783_7 crossref_primary_10_1007_s11164_019_04067_w crossref_primary_10_1016_j_ijpharm_2023_123529 crossref_primary_10_1021_acsapm_1c01262 crossref_primary_10_3390_encyclopedia2020052 crossref_primary_10_1016_j_carbpol_2021_118292 crossref_primary_10_1016_j_postharvbio_2010_08_012 crossref_primary_10_1016_j_biopha_2017_11_026 crossref_primary_10_1016_j_ejps_2012_08_003 crossref_primary_10_1080_24701556_2024_2355514 crossref_primary_10_1016_j_ijpharm_2012_02_038 crossref_primary_10_3390_polym12051122 crossref_primary_10_1007_s10725_011_9621_y crossref_primary_10_3390_ma14030478 crossref_primary_10_1021_acs_jafc_7b02616 crossref_primary_10_1039_D0RA06611G crossref_primary_10_1002_jrs_4255 crossref_primary_10_1007_s10311_011_0351_1 crossref_primary_10_1002_app_35646 crossref_primary_10_3390_ijms22126446 crossref_primary_10_1016_j_jddst_2020_101973 crossref_primary_10_1007_s11095_023_03486_0 crossref_primary_10_1016_j_ejpb_2017_04_028 crossref_primary_10_1016_j_carbpol_2016_01_024 crossref_primary_10_1039_C4PY00325J crossref_primary_10_3390_polym14030594 crossref_primary_10_1080_17425247_2019_1591365 crossref_primary_10_1021_acsanm_3c02026 crossref_primary_10_1039_C6RA06417E crossref_primary_10_1007_s10847_011_0101_9 crossref_primary_10_3762_bjoc_14_127 crossref_primary_10_1007_s10965_019_1754_0 crossref_primary_10_1007_s10853_020_05646_8 crossref_primary_10_1021_jp302047u crossref_primary_10_1007_s10847_010_9772_x crossref_primary_10_1016_j_jddst_2020_102275 crossref_primary_10_1016_j_jconrel_2022_09_063 crossref_primary_10_1016_j_carbpol_2017_05_086 crossref_primary_10_2174_1872210516666220905092202 crossref_primary_10_1039_c3sm50827g crossref_primary_10_1155_2016_9750785 crossref_primary_10_3762_bjoc_12_30 crossref_primary_10_1007_s10847_011_9926_5 crossref_primary_10_3109_03639045_2012_694610 crossref_primary_10_3390_app10238463 crossref_primary_10_1007_s12247_020_09442_4 crossref_primary_10_1016_j_jddst_2022_104065 crossref_primary_10_3390_pharmaceutics13040513 crossref_primary_10_1021_acs_chemrev_6b00525 crossref_primary_10_3390_ijms23084102 crossref_primary_10_47583_ijpsrr_2022_v76i01_026 crossref_primary_10_1016_j_ijpharm_2012_12_031 crossref_primary_10_1016_j_jddst_2020_102003 crossref_primary_10_1021_jp303006a crossref_primary_10_1016_j_csbj_2024_02_011 crossref_primary_10_3390_ijms25063527 crossref_primary_10_1016_j_jddst_2020_102089 crossref_primary_10_1016_j_jconrel_2015_12_046 crossref_primary_10_18231_j_ijpp_2023_031 crossref_primary_10_1007_s10847_012_0106_z crossref_primary_10_1007_s10853_021_06110_x crossref_primary_10_1007_s10847_010_9765_9 crossref_primary_10_1016_j_jddst_2022_103696 crossref_primary_10_2174_2211738507666190919121445 crossref_primary_10_1016_j_ijpharm_2010_09_025 crossref_primary_10_1016_j_jhazmat_2014_03_044 crossref_primary_10_3390_polym9010010 |
| Cites_doi | 10.1021/bc034186d 10.1002/(SICI)1521-3935(19990701)200:7<1644::AID-MACP1644>3.0.CO;2-P 10.1007/s10847-006-9270-3 10.1007/s10847-006-9085-2 10.1007/s10847-006-9216-9 10.1016/j.ijpharm.2005.05.042 10.1021/cm981090y 10.1016/j.eurpolymj.2006.05.005 10.1016/j.polymer.2006.10.011 10.1016/j.tca.2006.02.024 10.1016/S0032-9592(03)00258-9 |
| ContentType | Journal Article |
| Copyright | Copyright Taylor & Francis Group, LLC 2009 |
| Copyright_xml | – notice: Copyright Taylor & Francis Group, LLC 2009 |
| DBID | AAYXX CITATION |
| DOI | 10.1163/156855408X379388 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering |
| EISSN | 1568-5543 |
| EndPage | 48 |
| ExternalDocumentID | 10_1163_156855408X379388 9742418 |
| Genre | Articles |
| GroupedDBID | 0BK 0R~ 29F 30N 4.4 5GY 63Z AAAVI AAENE AAJMT AALDU AAMIU AAPUL AAQRR ABBKH ABCCY ABDBF ABFIM ABJVF ABLIJ ABPEM ABPTK ABQHQ ABTAI ABXUL ACGFS ACTIO ADCVX ADGTB AEGYZ AEISY AENEX AEOZL AEPSL AEVUW AEYOC AFOLD AFWLO AGDLA AGMYJ AHDLD AIJEM AIRXU AKBVH AKOOK ALMA_UNASSIGNED_HOLDINGS ALQZU AMFWP AQRUH AVBZW BLEHA CAG CCCUG COF CS3 DGEBU DKSSO DU5 EAP EBS EJD EMK EPL EST ESX E~A E~B FUNRP FVPDL GCUZY GTTXZ H13 HZ~ H~P I-F IL9 IPNFZ J.P KYCEM M4Z MK~ NZ- O9- P2P RIG RNANH ROL ROSJB RTWRZ S-T SNACF TEX TFL TFT TFW TTHFI TUS UT5 V1K ZGOLN 07S 5VS AANMX AATVF AAYXX ABCES ABGQB ABJNI ABPAQ ABXYU ABZIJ ACKDS ACLZH ACMRT AFDUV AFGMD AHDZW AIPZZ AMATQ ASQZU AWYRJ BVUPT C09 CITATION DGEYW DWNMW EBKLY ECKKI EXXQB HF~ JHRKR KC5 LJTGL MM1 NUSFT QSQFL S7E TBQAZ TCJPB TDBHL TFMCV TUROJ |
| ID | FETCH-LOGICAL-c295t-a54e4bfcfd4ddafce67b4ec6a089fdb93387734a43375b6d948cf3f073f7cd073 |
| ISSN | 0927-6440 |
| IngestDate | Thu Sep 12 19:09:42 EDT 2024 Tue Jun 13 19:32:51 EDT 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c295t-a54e4bfcfd4ddafce67b4ec6a089fdb93387734a43375b6d948cf3f073f7cd073 |
| PageCount | 10 |
| ParticipantIDs | crossref_primary_10_1163_156855408X379388 informaworld_taylorfrancis_310_1163_156855408X379388 |
| PublicationCentury | 2000 |
| PublicationDate | 2009-01-01 |
| PublicationDateYYYYMMDD | 2009-01-01 |
| PublicationDate_xml | – month: 01 year: 2009 text: 2009-01-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationTitle | Composite interfaces |
| PublicationYear | 2009 |
| Publisher | Taylor & Francis Group |
| Publisher_xml | – name: Taylor & Francis Group |
| References | Berto S. (CIT0012) 2007; 57 Garcia-Zubiri I. X. (CIT0007) 2006; 444 Cavalli R. (CIT0013) CIT0010 CIT0001 Swaminathan S. (CIT0011) 2007; 57 None E. M. (CIT0002) 2004; 39 Trotta F. (CIT0009) 2003 Gomez C. G. (CIT0005) 2006; 47 CIT0003 CIT0004 CIT0006 CIT0008 Trotta F. (CIT0014) |
| References_xml | – ident: CIT0003 doi: 10.1021/bc034186d – volume-title: 14th Intl. Cyclodextrin Sympos ident: CIT0013 contributor: fullname: Cavalli R. – ident: CIT0006 doi: 10.1002/(SICI)1521-3935(19990701)200:7<1644::AID-MACP1644>3.0.CO;2-P – volume: 57 start-page: 637 year: 2007 ident: CIT0012 publication-title: J. Incl. Phenom. Macrocycl. Chem. doi: 10.1007/s10847-006-9270-3 contributor: fullname: Berto S. – ident: CIT0010 doi: 10.1007/s10847-006-9085-2 – volume: 57 start-page: 337 year: 2007 ident: CIT0011 publication-title: J. Incl. Phenom. Macrocycl. Chem. doi: 10.1007/s10847-006-9216-9 contributor: fullname: Swaminathan S. – ident: CIT0001 doi: 10.1016/j.ijpharm.2005.05.042 – ident: CIT0008 doi: 10.1021/cm981090y – volume-title: National Cyclodextrin Symposium ident: CIT0014 contributor: fullname: Trotta F. – ident: CIT0004 doi: 10.1016/j.eurpolymj.2006.05.005 – volume: 47 start-page: 8509 year: 2006 ident: CIT0005 publication-title: Polymer doi: 10.1016/j.polymer.2006.10.011 contributor: fullname: Gomez C. G. – volume: 444 start-page: 57 year: 2006 ident: CIT0007 publication-title: Termochim. Acta. doi: 10.1016/j.tca.2006.02.024 contributor: fullname: Garcia-Zubiri I. X. – volume: 39 start-page: 1033 year: 2004 ident: CIT0002 publication-title: Proc. Biochem. doi: 10.1016/S0032-9592(03)00258-9 contributor: fullname: None E. M. – volume-title: Cross-linked polymers based on cyclodextrin for removing polluting agents year: 2003 ident: CIT0009 contributor: fullname: Trotta F. |
| SSID | ssj0024070 |
| Score | 2.2154717 |
| Snippet | Nanosponges are recently developed hyper-cross-linked cyclodextrin polymers nanostructured to form 3-dimensional networks; they are obtained by reacting... |
| SourceID | crossref informaworld |
| SourceType | Aggregation Database Publisher |
| StartPage | 39 |
| SubjectTerms | CYCLODEXTRIN DECONTAMINATION DRUG DELIVERY INCLUSION COMPLEX NANOSPONGES |
| Title | Characterization and Applications of New Hyper-Cross-Linked Cyclodextrins |
| URI | https://www.tandfonline.com/doi/abs/10.1163/156855408X379388 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA-6XfQgfuL8ogcvItHafDQ9jqlMQU8Th5fSpAkIskmtiP71vjRd13UKuktbShvavB8v7yPv9xA6tjZ2FEiGL4iOMGVG4Sj0E8wF830TcCGorXe-u-f9B3o7ZMNJi_uyuiSXZ-rrx7qSRaQK90Cutkr2H5KtBoUbcA3yhSNIGI5_knGvYlt2xZRFJqBbS0kX8QD9cdoHbzPDPbsiYut92rDup3qx5ex59lwG7CZ8BaAh7E4uXVBJZMbu2ar8-2ycO3OzaMih39R4msSAP3O11m63djITUIgaAYXBXG-PWhisDB0GIQY7yuVTdKk4bQUXc5RLlWblcwhyatLxF5ULrmPanFfl3FJK2HFhWF8MCWgS1wGwQZANHhGYIWIZtQN4BLRcu9u_fHqcMi76RcvA6qsnyWpOzpujzxgnM9S1NaNjsI7WSm_B6zrRb6AlPdpEqzUOyS100wSBByDw6iDwxsYDEHjzIPBmQLCNHq6vBr0-LvtjYBVELMcJo5pKo0xK0zQxSvNQUq144ovIpDIiRIQhoQklJGSSpxEVyhADSt2EKoXTDmqNxiO9izxBjIAl2EgGM0Q4aHXNuQyUDkRhlXfQyWRi4ldHgxIX7iMncXMSO4jWZy7OC0AZh6WY_Pba3mKv7aOVKYgPUCvP3vUh2Im5PCqB8A22AWcy |
| link.rule.ids | 315,783,787,27936,27937,60214,61003 |
| linkProvider | Library Specific Holdings |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELagDMDAG1GeGVgYXEz8iD1WEVUKbadW6hbFjr2AWtSmA_x67DiFtIKlUyY7sn2-u-989x0A987HFqGk8AlrAQk1CooIZZBxipAJGefE1Tv3BywZkZcxHVe5OfMqrdJhaOOJIkpd7S63C0b7G87wo8UcLrsK8TG24sX5NthhjvvLVXCgwS_VHip7xSERRtCafbR8pfxjhhWrtMJZWrM2nUPfUnVekhS6JJO31qKQLfW1RuG48UKOwEHlhwZtLzjHYEtPTsB-jZ3wFHTjHzJnX6sZ2B8F7dqLdzA1gdWSQWLB7AzGbmnQgVudB_GnenfV8oWda34GRp3nYZzAqvMCVKGgBcwo0UQaZXKS55lRmkWSaMUyxIXJpbC4NoowyQjGEZUsF4Qrg41VFyZSuf2cg8ZkOtEXIODYcKvcjaT2CDCz-kIzJkOlQ176e03wsNz59MMTbKQlMGE4Xd-eJiD1o0mLMqhhfAeSFP837HKzYXdgNxn2e2mvO3i9Anv-GcnFXq5Bo5gt9I31Rgp5W8rcN3BV1aE |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED6VIiEYeCPKMwMLg4uJH3EklipQtTwqBip1QVHs2AuorUo6wK_HThpIK1g6ZbId2-fzfb677wAunI0d-pKha6JDRJlRKAxwgrhgGBufC0FdvvNTj3f69H7ABjW4KXNhXFilw9CmIIrIdbU73OPUFAeckysLOVxwFRYDYqVLiBVYtUYAdlJOcO-XaQ_npeJw6AfI3vq4dFL-0cPcpTRHWVq5bNpb8Fr-ZhFj8tacZrKpvhYYHJedxzZszqxQr1WIzQ7U9HAXNirchHvQjX6onItMTc-O47Uq_m5vZDyrI72OhbITFLmZIQdtdepFn-rd5cpntq-Pfei3716iDprVXUDKD1mGEkY1lUaZlKZpYpTmgaRa8QSL0KQytKg2CAhNKCEBkzwNqVCGGKssTKBS-zmA-nA01IfgCWKEVe1GMrsDhFttoTmXvtK-yK29BlyWCx-PC3qNOIclnMSLy9MAWt2ZOMufNExRfyQm_zU7Wq7ZOaw937bjx27v4RjWCx-Se3g5gXo2mepTa4pk8iyXuG8LEdRO |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+and+Applications+of+New+Hyper-Cross-Linked+Cyclodextrins&rft.jtitle=Composite+interfaces&rft.au=Trotta%2C+Francesco&rft.au=Cavalli%2C+Roberta&rft.date=2009-01-01&rft.pub=Taylor+%26+Francis+Group&rft.issn=0927-6440&rft.eissn=1568-5543&rft.volume=16&rft.issue=1&rft.spage=39&rft.epage=48&rft_id=info:doi/10.1163%2F156855408X379388&rft.externalDocID=9742418 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0927-6440&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0927-6440&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0927-6440&client=summon |